These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26352006)

  • 1. Pharmacotherapeutic management of erectile dysfunction.
    Hawksworth DJ; Burnett AL
    Clin Pharmacol Ther; 2015 Dec; 98(6):602-10. PubMed ID: 26352006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis.
    Fanbin L; Mei Y; Yan Z; Yirong Y; Shaoling Z; Yong C; Peng X
    Exp Clin Transplant; 2014 Jun; 12(3):184-9. PubMed ID: 24907716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer phosphodiesterase inhibitors: comparison with established agents.
    McNamara ER; Donatucci CF
    Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management.
    Hernández-Cerda J; Bertomeu-González V; Zuazola P; Cordero A
    Vasc Health Risk Manag; 2020; 16():231-239. PubMed ID: 32606719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
    Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
    Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk.
    Nehra A; Jackson G; Miner M; Billups KL; Burnett AL; Buvat J; Carson CC; Cunningham GR; Goldstein I; Guay AT; Hackett G; Kloner RA; Kostis J; Montorsi P; Ramsey M; Rosen RC; Sadovsky R; Seftel AD; Vlachopoulos C; Wu FC
    J Urol; 2013 Jun; 189(6):2031-8. PubMed ID: 23313195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.
    Basal S; Wambi C; Acikel C; Gupta M; Badani K
    BJU Int; 2013 Apr; 111(4):658-65. PubMed ID: 23186312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases.
    Cai Z; Zhang J; Li H
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):119-128. PubMed ID: 30675707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H; Gacci M; Büttner H; Henneges C; Boess F
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for the treatment of erectile dysfunction.
    Peak TC; Yafi FA; Sangkum P; Hellstrom WJ
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):263-75. PubMed ID: 25740087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.
    Kaiho Y; Yamashita S; Arai Y
    Int J Urol; 2013 Mar; 20(3):285-9. PubMed ID: 23311962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of the position paper on arterial hypertension and erectile dysfunction.
    Viigimaa M; Vlachopoulos C; Doumas M; Wolf J; Imprialos K; Terentes-Printzios D; Ioakeimidis N; Kotsar A; Kiitam U; Stavropoulos K; Narkiewicz K; Manolis A; Jelakovic B; Lovic D; Kreutz R; Tsioufis K; Mancia G;
    J Hypertens; 2020 Jul; 38(7):1220-1234. PubMed ID: 32073535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future is today: emerging drugs for the treatment of erectile dysfunction.
    Albersen M; Shindel AW; Mwamukonda KB; Lue TF
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):467-80. PubMed ID: 20415601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
    Imprialos K; Koutsampasopoulos K; Manolis A; Doumas M
    Curr Vasc Pharmacol; 2021; 19(3):301-312. PubMed ID: 32286949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INN common stem: -afil.
    Prescrire Int; 2014 Apr; 23(148):94. PubMed ID: 24860892
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
    Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Phosphodiesterase-5 Inhibitors in Valvular Heart Disease.
    Gopal A; Sharma T; Calkins JB
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):372-376. PubMed ID: 34074904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities].
    Puigvert AM; Prieto R; García F
    Rev Int Androl; 2018; 16(1):28-33. PubMed ID: 30063020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging and sexual health: getting to the problem.
    Kaya E; Sikka SC; Kadowitz PJ; Gur S
    Aging Male; 2017 Jun; 20(2):65-80. PubMed ID: 28590829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.